Table 2.
Symptoms at Enrollment and Clinical Outcomes for Patients with RSV and HMPV
| Characteristic | RSV infection (n = 32) | HMPV infection (n = 33) | p value |
|---|---|---|---|
|
| |||
| Duration of Symptoms in days, median (25%, 75%) | 4 (2, 6) | 3 (2, 4) | 0.670 |
|
| |||
| Symptoms/Signs, n (%) | |||
| Congestion/Rhinorrhea | 25 (78.1) | 24 (72.7) | 0.614 |
| Sore throat | 19 (59.4) | 13 (39.4) | 0.107 |
| Cough | 29 (90.6) | 32 (97) | 0.287 |
| Dyspnea | 30 (93.8) | 32 (97) | 0.536 |
| Wheezing | 29 (90.6) | 26 (78.8) | 0.186 |
| Earache | 11 (34.4) | 6 (18.2) | 0.137 |
| Fever | 19 (59.4) | 23 (69.7) | 0.461 |
| GI symptoms | 13 (40.6) | 18 (54.6) | 0.261 |
| Decreased appetite | 23 (71.9) | 25 (75.8) | 0.722 |
| Myalgias | 17 (53.1) | 19 (57.6) | 0.718 |
| Headache | 21 (65.6) | 19 (57.6) | 0.505 |
| Fatigue | 31 (96.9) | 27 (81.8) | 0.050 |
| Altered mental status | 7 (21.9) | 9 (27.3) | 0.614 |
|
| |||
| Clinical Outcomes among those hospitalized N | N=24 | N=27 | |
|
| |||
| Length of Stay in days, median (25%, 75%) | 4 (2, 5) | 3 (2, 4) | 0.877 |
|
| |||
| ICU admission, n (%) | 4 (16.7) | 2 (7.4) | 0.306 |
|
| |||
| Length of Stay in ICU in days, median (25%, 75%) | 3 (2.5, 5.0) | 4·5 (1.0, 8.0) | 0.489 |
|
| |||
| Need for Mechanical Ventilation, n (%) | 1 (4.2) | 0 (0) | 0.284 |
|
| |||
| Death, n (%) | 1 (4.2) | 0 (0) | 0.284 |